A meeting of the Board of Directors of Solara Active Pharma Sciences Limited is scheduled to be held on Friday, October 16, 2026. The primary agenda is to consider and approve the unaudited financial results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. The board may also discuss other matters.
In accordance with the Company's Code of Conduct for Prohibition of Insider Trading, adopted pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company has been closed for all designated persons. The closure period began on October 01, 2026, and will remain in effect until 48 hours after the financial results are officially announced to the public.
This intimation is made in compliance with Regulation 29 of the SEBI Listing Regulations. The information is also available on the company's website at www.solara.co.in.
The disclosure is signed by Pooja Jaya Kumar, Company Secretary & Compliance Officer (Membership No: A57415), on behalf of Solara Active Pharma Sciences Limited.